🛏️ Zepbound Insurance coverage for Sleep Apnea

Research leads to FDA approval leads to Insurance coverage

The list of benefits of the GLP1 Receptor Agonist class of drugs keeps growing, and more FDA approvals means more coverage by insurance companies.

Recently, the Centers for Medicare and Medicaid released a statement confirming that Zepbound would be covered given it’s effectiveness in treating Sleep Apnea.

This is a huge step forward for those looking to get covered under insurance for affordable access to GLP1 medication, and of course a huge improvement in the treatment for Sleep Apnea as Zepbound was the *first* drug to be approved for that use.